However, the NLRP3 inflammasome is essential for antitumor adaptive immunity in bladder cancer (BC) and renal cell carcinoma (RCC), and its pyroptosis pathway has demonstrated potent antitumor effects. The gene discussed is NLRP3; the disease is urinary bladder cancer.